1. Home
  2. MCI vs SRDX Comparison

MCI vs SRDX Comparison

Compare MCI & SRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MCI
  • SRDX
  • Stock Information
  • Founded
  • MCI 1971
  • SRDX 1979
  • Country
  • MCI United States
  • SRDX United States
  • Employees
  • MCI N/A
  • SRDX N/A
  • Industry
  • MCI Trusts Except Educational Religious and Charitable
  • SRDX Medical/Dental Instruments
  • Sector
  • MCI Finance
  • SRDX Health Care
  • Exchange
  • MCI Nasdaq
  • SRDX Nasdaq
  • Market Cap
  • MCI 436.4M
  • SRDX 415.4M
  • IPO Year
  • MCI N/A
  • SRDX 1998
  • Fundamental
  • Price
  • MCI $21.48
  • SRDX $30.29
  • Analyst Decision
  • MCI
  • SRDX Buy
  • Analyst Count
  • MCI 0
  • SRDX 2
  • Target Price
  • MCI N/A
  • SRDX $43.00
  • AVG Volume (30 Days)
  • MCI 40.4K
  • SRDX 91.6K
  • Earning Date
  • MCI 01-01-0001
  • SRDX 07-30-2025
  • Dividend Yield
  • MCI 8.46%
  • SRDX N/A
  • EPS Growth
  • MCI N/A
  • SRDX N/A
  • EPS
  • MCI 1.82
  • SRDX N/A
  • Revenue
  • MCI N/A
  • SRDX $121,575,000.00
  • Revenue This Year
  • MCI N/A
  • SRDX N/A
  • Revenue Next Year
  • MCI N/A
  • SRDX $3.19
  • P/E Ratio
  • MCI $9.88
  • SRDX N/A
  • Revenue Growth
  • MCI N/A
  • SRDX N/A
  • 52 Week Low
  • MCI $12.96
  • SRDX $26.00
  • 52 Week High
  • MCI $19.24
  • SRDX $41.98
  • Technical
  • Relative Strength Index (RSI)
  • MCI 53.65
  • SRDX 60.91
  • Support Level
  • MCI $20.84
  • SRDX $30.50
  • Resistance Level
  • MCI $21.79
  • SRDX $31.63
  • Average True Range (ATR)
  • MCI 0.53
  • SRDX 0.92
  • MACD
  • MCI -0.07
  • SRDX 0.10
  • Stochastic Oscillator
  • MCI 47.37
  • SRDX 81.07

About MCI Barings Corporate Investors

Barings Corporate Investors is a closed-end management investment company. Its investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. The Trust's principal investments are privately placed, below-investment grade, long-term debt obligations, including bank loans and mezzanine debt instruments. The Trust typically purchases these investments, which are not publicly tradable, directly from their issuers in private placement transactions, and the investments are typically made to small or middle market companies.

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

Share on Social Networks: